Stock Ratings / Consumer Staples / YI / dividends

PETS (26) RDGT (43) GRDN (77) CVS (61) ⌘ Pro Terminal →

111 Inc. (YI) Dividend Safety Gauge & 10-Year DRIP Compounder

$2.98 +0.34% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.98

111 Inc. (YI) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • SELL / AVOID Cap $26.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.98 (-0.13%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 0.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.0% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D-

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-7% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for YI)Realized 20D OHLCV Swing Band: ±9.4%

Deterministic 5-Pillar Attribution (42/100 Composite)

🔍 WHY YI SCORES 42/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+12/20 pts (29% of score)

Altman Z-Score 3.34 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9

▲ #2 Bullish Driver: Cash Engine Quality+9/20 pts (21% of score)

SEC XBRL FY 2025 (10-K): 0.9% FCF Margin ($16.4M FCF) & 5.8% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C-$3.15-0.6% Next Q

Q2 (-2Q)

Grade D$3.13-8.6% Next Q

Q3 (-1Q)

Grade D$2.86+4.2% Next Q

Current

Grade D-$2.98-7% Hist 90D α

Trajectory: C- (50) → D- (42)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a YI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While YI currently carries a cautious 42/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Staples with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.32) and Max Pain ($3.13) forces dealer call-delta covering toward $11.73.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $YI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “YI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 42%NO 58%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $17,081

Est. Year-10 Shareholder Yield: $307/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.6K

Yr 1

$11.1K

Yr 2

$11.7K

Yr 3

$12.4K

Yr 4

$13.1K

Yr 5

$13.8K

Yr 6

$14.5K

Yr 7

$15.3K

Yr 8

$16.2K

Yr 9

$17.1K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring YI)

✓Walkthrough of YI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

YI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -51.94%📐 HORIZONTAL RANGE

2026-10-30O $2.94H $2.98L $2.85C $2.98VOL 21.6K

RES: $4.06SUP: $2.00SMA50: $3.32SMA200: $5.06

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

YI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 YI Butterfly Map → + Track YI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -9.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on YI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for YI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for YI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (YI)

Consumer Staples Rank #116 of 146 ⚔️ PETS vs YI Full Matrix →

1. Head-to-Head Consumer Staples Peer Comparison (YI vs. PETS, RDGT, GRDN, CVS)

Industry: Retail-Drug Stores and Proprietary Stores (5 Tracked Issuers)

Across 146 tracked Consumer Staples securities in the Roarable RQD universe, 111 Inc. (YI) ranks #116 by composite RQD confidence (42/100, grade D-) and #116 by equity capitalization ($26.2M). Within this direct 5-issuer industry benchmark cohort, GRDN leads on earnings valuation at 52.1x trailing P/E, while GRDN leads on capital efficiency and profitability with 37.7% ROIC and 20.2% gross margin. GRDN currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with YI at 42/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
YI ACTIVE 111 Inc.	D-	42/100	—	5.8%	-20.5%	+0.34%	$26.2M	Benchmark Subject
PETS PetMed Express Inc.	E	26/100	—	28.1%	-35.0%	-0.84%	$25.6M	/pets-vs-yi →
RDGT Ridgetech Inc.	D-	43/100	—	3.6%	—	-2.45%	$3.0M	/rdgt-vs-yi →
GRDN Guardian Pharmacy Services Inc. (Class A)	B+	77/100	52.1x	20.2%	37.7%	+0.30%	$2.56B	/grdn-vs-yi →
CVS CVS Health Corporation	C-	61/100	65.3x	45.0%	2.6%	+0.42%	$115.53B	/cvs-vs-yi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001738906

In its most recent audited fiscal period (FY2025, filed 2025-12-31), 111 Inc. (YI) reported GAAP revenue of $1.80B (-9.0% vs. FY2024 revenue of $1.97B , and -14.7% cumulative change since FY2023) , GAAP net income of $0, operating cash flow of $17.0M, and free cash flow of $16.4M (-51.7% YoY). On the balance sheet, YI closed FY2025 with $314.6M in total assets against $0 in total debt (Altman Z-Score: 3.34, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.80B	$0	$17.0M	$16.4M	$314.6M	—
FY2024 (FY)	2024-12-31	$1.97B	$0	$36.0M	$34.0M	$381.9M	—
FY2023 (FY)	2023-12-31	$2.11B	$0	-$63.0M	-$63.0M	—	—

3. YI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is YI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, 111 Inc. (NASDAQ: YI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $2.98 (+0.34% 1D, market cap $26.2M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 146 tracked Consumer Staples issuers, YI ranks #116 in composite RQD confidence.

How does YI compare to PETS and RDGT in the Consumer Staples sector?

Within the Consumer Staples sector (Retail-Drug Stores and Proprietary Stores), YI carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of 5.8%, and ROIC of -20.5%. By comparison, PETS (PetMed Express Inc.) holds a E grade (26/100 RQD, P/E N/A, ROIC -35.0%, cap $25.6M) and RDGT (Ridgetech Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC —, cap $3.0M). Among the 5-stock peer group, GRDN leads on earnings multiple (52.1x) while GRDN leads on capital efficiency (37.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for YI?

Per YI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001738906), 111 Inc. generated $1.80B in revenue (-9.0% YoY), $0 in net income, and $16.4M in free cash flow against $314.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Staples with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is YI trading relative to its 50-day, 200-day, and 52-week technical levels?

YI last traded at $2.98 (+0.34% on volume of 100,412 shares), positioning the stock -10.24% below its 50-day simple moving average ($3.32) and -41.11% below its 200-day simple moving average ($5.06). Across its 52-week range of $2.48 to $11.17, YI sits at the 5.8% percentile with a 14-day RSI of 32.8 (NEUTRAL RANGE) and an implied next-earnings move of ±9.4% ($2.70 to $3.26).

YI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does YI pay a dividend and is it safe?

111 Inc. (YI) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: YI RQD Cockpit YI 12M Forecast YI Earnings & Move YI Dividends & DRIP YI Insiders & 13F YI Whale Options YI Profit Sankey YI News & Why